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Abstract
Background: TATA-box-binding protein 2 (TBP2/TRF3) is a vertebrate-specific paralog of TBP
that shares with TBP a highly conserved carboxy-terminal domain and the ability to bind the TATA
box. TBP2 is highly expressed in oocytes whereas TBP is more abundant in embryos.
Results: We find that TBP2 is proteolytically degraded upon meiotic maturation; after germinal
vesicle breakdown relatively low levels of TBP2 expression persist. Furthermore, TBP2 localizes to
the transcriptionally active loops of lampbrush chromosomes and is recruited to a number of
injected promoters in oocyte nuclei. Using an altered binding specificity mutant reporter system
we show that TBP2 promotes RNA polymerase II transcription in vivo. Intriguingly, TBP, which in
oocytes is undetectable at the protein level, can functionally replace TBP2 when ectopically
expressed in oocytes, showing that switching of initiation factors can be driven by changes in their
expression. Proteolytic degradation of TBP2 is not required for repression of transcription during
meiotic maturation, suggesting a redundant role in this repression or a role in initiation factor
switching between oocytes and embryos.
Conclusion: The expression and transcriptional activity of TBP2 in oocytes show that TBP2 is the
predominant initiation factor in oocytes, which is substituted by TBP on a subset of promoters in
embryos as a result of proteolytic degradation of TBP2 during meiotic maturation.
Background
A key regulatory step in eukaryotic transcription initiation
is the assembly of basal transcription apparatus at the core
promoter. This apparatus includes RNA polymerase II
(pol-II) and a set of basal transcription factors. For a long
time the basal transcriptional machinery was thought to
be universal and mainly invariant across different pro-
moters. However, a growing body of evidence points
towards a more dynamic and regulatory role for this
machinery (reviewed in [1-4]). TATA-box binding protein
(TBP) was once thought to be the general transcription
factor involved in all transcription in eukaryotic cells. In
higher eukaryotes, however, a number of TBP paralogs are
present and there is clear evidence for TBP-independent
transcription in a variety of model organisms [5-12]. So
far three TBP paralogs have been described in metazoans;
the insect-specific TBP-related factor 1 (TRF1) [13], the
metazoan-specific TBP-like factor (TLF, also known as
TRF2, TLP or TBPL1) [1] and the vertebrate-specific factor
TBP2 (also known as TRF3 or TBPL2) [8,12,14].
TBP2 is the most closely related TBP paralog, sharing 95%
sequence identity in the core domain [8,12,14]. It can
bind to TATA box, interacts with TFIIA and TFIIB and pro-
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motes basal transcription in vitro. In addition, knockdown
studies in fish and frogs showed that TBP2 is indispensa-
ble for embryonic development [8,12] and is preferen-
tially required for the transcription of embryonic
vertebrate-specific genes and those involved in ventral
specification during gastrulation in Xenopus [9]. TBP2 is
also essential in differentiation pathways in zebrafish and
mouse [10,11]. Although some TBP2 is present and
required in early Xenopus embryos, it is most abundant in
oocytes, suggesting that TBP2 has an important role in
oocyte transcription [8]. Here we provide functional evi-
dence for the role of TBP2 in pol-II transcription by exam-
ining its binding to oocyte chromosomes and pol-II
promoters, and by employing in vivo transcriptional
assays involving an altered binding specificity mutant
reporter system. We show that TBP2 is localized to active
promoters in oocytes and can promote pol-II transcrip-
tion. TBP2 is degraded during meiotic maturation. Sur-
prisingly, TBP, when exogenously expressed in oocytes,
can substitute for TBP2, which is indicative of dynamic
and rapidly adaptable nature of core transcription
machinery. Together, these observations establish the
involvement of TBP2 in transcription initiation of
oocytes. Moreover the proteolytic degradation of TBP2
during meiotic maturation is relevant for the initiation
factor switching that occurs during the course of early
development.
Methods
Constructs
The Xenopus TBP (pSP64A-xTBP) [15] and TBP2 (pT7TSA-
xTBP2) [8] constructs were utilized to generate altered
binding specificity mutant versions of these proteins by
introducing three point mutations in the carboxy-termi-
nal domain of xTBP (I250F, V259T and L261V) and
xTBP2 (I273F, V282T and L282V) using the Quick Change
site-directed mutagenesis kit (Stratagene). Capped
mRNAs were transcribed by an in vitro RNA synthesis kit
(Ambion, Austin, TX). pCMV-CAT and pG4-hsp70-CAT
have already been described [16] whereas pG4-BLCAT-
ZFP36L2, pG4-BLCAT-TLF, pG4-BLCAT-polr2h and pG4-
BLCAT-Cyr61 and pG4-BLCAT-intron (containing an
intronic fragment of the WD repeat domain 42A (wdr42a)
gene) were generated by cloning these promoters ampli-
fied from X. tropicalis genomic DNA, into pG4-BLCAT2
[17] at the BamHI and XhoI sites (WA and GJCV, manu-
script in preparation).
Germinal vesicle spreads and immunofluorescence
Germinal vesicle (GV) spreads were prepared as described
in [18] with minor modifications. Defolliculated stage VI
oocytes were transferred one at a time to isolation
medium (83 mM KCl, 17 mM NaCl, 6.5 mM Na2HPO4,
3.5 mM KH2PO4, 1 mM MgCl2, 1 mM dithiothreitol, pH
7.0). The GV was isolated, the nuclear membrane was
removed and the contents of GV quickly transferred to 20
μl of spreading medium containing 1% paraformalde-
hyde and 0.15% Triton X-100 on a glass cover slip. The
cover slips were kept at room temperature for 1 hr before
being stored in phosphate-buffered saline (PBS). GV
spreads were rinsed in PBS containing 0.2% Tween and
blocked with 0.5% bovine serum albumin and 0.4% gel-
atin followed by 1 hr incubations with primary and sec-
ondary antibodies at room temperature. TBP2 antibody
1G6 has already been described [8] whereas 3E6 is a
mouse monoclonal antibody raised against the amino-
terminal domain of Xenopus TBP2. The secondary anti-
body was Alexa 488-labelled goat anti-mouse immu-
noglobulin G (IgG) in a 1:100 dilution also containing 4
μg/ml 4',6-diamidino-2-phenylindole (DAPI). Images
were taken with Zeiss Axiophot2 Fluorescence micro-
scope.
Microinjections and primer extension
Defolliculated oocytes were injected with 1 ng of in vitro-
transcribed TBP/2-abs RNA in the cytoplasm using a
Drummond Nanoject microinjection apparatus (Drum-
mond Scientific, Broomall, PA). After a delay of 4 hr, GVs
of these oocytes were injected with different amounts of
plasmid constructs as indicated in the text and figure leg-
ends. The next day the oocytes were collected and RNA
was isolated using Trizol (Invitrogen) extraction and LiCl
precipitation. The RNA equivalent to four oocytes was
analyzed by primer extension as described in [17].
Meiotic maturation and western blotting
Stage VI oocytes were incubated at 18°C in MBSH buffer
containing 1 μg/ml progesterone (Sigma). Maturing
oocytes were synchronized at germinal vesicle break down
(GVBD) and then collected at different time points as
indicated in the figure legends. Extracts from collected
oocytes were prepared as previously described [15]. The
antibodies used were anti-TBP 58C9, anti-TFIIB C-18,
anti-TFIIF RAP 74 C-18, anti-Mos C237 (Santa Cruz Bio-
technology), anti-phospho-p44/42 MAP Kinase (Cell Sig-
nalling Technology), anti-TBP SL27, SL30 and SL33 [19]
and anti-H3 core and anti-H3Ser10P (Abcam).
Chromatin immunoprecipitation
Stage VI oocytes were injected with promoter constructs
(for amounts see the figure legends) in the nucleus. After
overnight incubation at 18°C, oocytes were cross-linked
and processed for chromatin immunoprecipitation
(ChIP) as described previously [8]. For ChIP of HA-tagged
TBP, 2 ng mRNA encoding HA-TBP2 was injected in the
cytoplasm 4 hr prior to nuclear injections. The antibodies
used were anti TBP-2 1G6 [8], anti-RNA polymerase II
(Diagenode) and anti-HA (Covance).BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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Electrophoretic mobility shift assay
An electrophoretic mobility shift assay (EMSA) was per-
formed essentially as described in [20] and [21].
Results
Regulated proteolytic degradation of TBP2 during meiotic 
maturation
TBP accumulates due to regulated translation of TBP
mRNA during cleavage stages of development [15],
whereas it is not detectable in oocytes (Figure 1A, see
[8,15]). TBP2, by contrast, is very abundant in oocytes but
is expressed at very low levels in embryos, suggesting that
TBP2 is a replacement core promoter factor for TBP in
oocytes [8,22]. To examine the possibility that the lack of
detection of TBP in oocytes is due to a modification of TBP
in these cells that masks its epitope, we probed oocyte
(prophase of meiosis I-arrested), egg (metaphase of meio-
sis II-arrested) and late blastula (stage 9) embryo extracts
with 58C9 antibody, which recognizes both TBP and
TBP2, and three different TBP-specific antibodies, SL27,
SL30 and SL33. None of the antibodies detect TBP in
oocytes (Figure 1A), confirming that there is very little if
TBP2 is actively down regulated upon meiotic maturation Figure 1
TBP2 is actively down regulated upon meiotic maturation. (A) Western blot analysis of TBP expression in oocytes, 
eggs and late blastula (stage 9) embryos with four different antibodies; 58C9, SL27, SL30 and SL33. Asterisk indicates non-spe-
cific bands. (B) Western blot analysis of TBP2 expression in oocyte germinal vesicles and embryonic nuclei with a TBP2-spe-
cific monoclonal antibody 3E6. (C) Stage VI Xenopus oocytes were incubated in MBSH buffer containing 1 μg/ml progesterone. 
Batches of 15 oocytes were collected at indicated time intervals and analyzed by western blotting. (D) Stage VI Xenopus 
oocytes injected with TBP and HA-TBP2 mRNA were incubated in MBSH buffer containing 1 μg/ml progesterone. Batches of 
15 oocytes were collected at indicated time intervals and analyzed by western blotting. (E) Oocytes expressing exogenous 
TBP were treated with either progesterone (1 μg/ml) or cycloheximide (15 μg/ml). Batches of 15 oocytes were collected 4 hr 
and 16 hr after the treatment and analyzed by western blotting. Asterisk indicates non-specific bands.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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any TBP present in Xenopus oocytes. Low levels of TBP are
detected in egg extracts, whereas it is very abundant in
embryos (Figure 1A), consistent with regulated transla-
tion of maternal TBP mRNA in cleavage-stage embryos
[15].
TBP2 on the other hand is abundant in oocytes, whereas
in eggs and early embryos very low levels of TBP2 are
present. This was also observed when oocyte GV and
embryonic nuclear extracts were probed with a TBP2-spe-
cific monoclonal antibody 3E6 (Figure 1B). The mecha-
nism of the decrease in TBP2 expression, however, is
unknown. To investigate this issue we followed the TBP2
levels during the course of oocyte maturation. This can be
done in vitro by treating fully grown stage VI oocytes with
progesterone. The maturation is marked by the appear-
ance of a spot on the animal pole of the oocyte as a result
of GVBD. TBP2 levels start to drop within 30 min after
GVBD and by 4 hr the protein is hardly detectable (Figure
1C). This was further assessed by looking at some markers
of meiotic maturation in oocytes, including degradation
of cytoplasmic polyadenylation element binding protein
and phosphorylation of MAPK and histone H3 serine10.
TBP2 downregulation coincides with the accumulation of
Xenopus Mos protein (Figure 1C). The Mos protein is a
kinase that plays an important role in oocyte maturation.
In response to progesterone treatment, the translation of
Mos mRNA and the stability of the Mos protein increase,
resulting in the gradual accumulation of the protein [23].
To examine the kinetics of overexpressed TBP and TBP2 in
maturing oocytes, oocytes were injected with mRNA
encoding TBP and HA-TBP2 (which can be distinguished
from endogenous TBP2) and treated with progesterone.
The injected synthetic TBP mRNA lacks its native 5' and 3'-
UTR and is translated in oocytes, in contrast to the endog-
enous maternal TBP mRNA which is translationally
masked [15]. The kinetics of overexpressed TBP and TBP2
are similar, although the levels of endogenous TBP2 tend
to decrease more rapidly (Figure 1D), which may reflect
differences in expression level at the start of the experi-
ment.
To assess whether the decrease in TBP2 levels is due to
changes in translation or degradation, oocytes were
treated with the translation inhibitor cycloheximide. To
check translation efficiency under these conditions
oocytes were injected with TBP mRNA in the presence and
absence of this inhibitor. After 16 hr of incubation with
cycloheximide there was hardly any effect on TBP2 levels,
showing that TBP2 protein is quite stable in oocytes,
whereas in progesterone-treated cells TBP2 expression is
lost (Figure 1E). Therefore, proteolytic degradation of
TBP2 is markedly increased during meiotic maturation.
TBP, when ectopically expressed in oocytes, is also
degraded during maturation although residual levels after
maturation are substantially higher, similar to the situa-
tion when TBP2 is overexpressed (Figures 1D and 1E).
Intriguingly, even well after GVBD, TBP2 is not com-
pletely degraded, which is consistent with the observation
that some TBP2 persists in early Xenopus embryos (Figure
1A, see [8]).
TBP2 decorates lampbrush chromosomes
In the absence of TBP, TBP2 may be the major TATA box
binding initiation factor in oocytes, and as such should
localize to lampbrush chromosomes. These are partially
condensed paired chromosomes present in the GVs of
amphibian oocytes, arrested in the diplotene stage
(prophase) of meiosis I. Transcriptional activity is accom-
modated by numerous laterally extended loops along the
length of each of these chromosomes [24,25]. GV spreads
were prepared from stage VI oocytes and the chromosome
axis and the lateral loops were visualized using DAPI.
Interestingly, many loops are decorated with TBP2 (Figure
2) as shown with two different TBP2 monoclonal anti-
bodies. Nucleoli do not show any TBP2 staining; by con-
trast, Cajal bodies (CB) and B-snurposomes (BS), which
are considered to be the depositories of transcription
complexes and related proteins [18], stain positive. The
two TBP2 antibodies used recognize different epitopes on
TBP2 (data not shown) and show a similar staining of
TBP2 on lampbrush chromosomes and CB (Figure 2). The
recruitment of TBP2 to transcriptionally active chromo-
somal loops is in line with a major role of TBP2 in tran-
scription initiation in oocytes.
TBP2 is recruited to promoters in oocytes
To characterize the binding of TBP2 at a higher resolution,
promoter reporter constructs were injected into oocyte
TBP2 is recruited to transcriptionally active loops of lamp- brush chromosomes Figure 2
TBP2 is recruited to transcriptionally active loops of 
lampbrush chromosomes. Germinal vesical (GV) spreads 
were probed with TBP2 specific antibodies 1G6 (top panel) 
and 3E6 (bottom panel) as described in Methods. The inset 
shows a magnified chromosomal loop. Cajal bodies (CB) and 
B-snurposomes (BS) are indicated.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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nuclei and analyzed by ChIP. As a control for the activity
of these promoters we also performed ChIP with a pol-II
antibody. The results show that TBP2 is associated with
these promoters (Figure 3A). Although the recruitment is
variable, in all cases it is well above the recruitment to the
background control (construct containing an intronic
fragment of the WD repeat domain 42A (wdr42a) gene).
Furthermore, TBP2 recruitment correlates with the occu-
pancy of pol-II. TBP2 was also enriched on the endog-
enous amplified 5S rRNA loci which recruited very little
pol-II, as expected for RNA polymerase-III promoters.
To further confirm the association of TBP2 with promot-
ers in oocytes, we expressed an HA-tagged version of TBP2
in oocytes and tested the recruitment of TBP2 on these
promoters with an anti-HA antibody. Oocytes injected
with promoter constructs but lacking HA-TBP2 were used
as a negative control. A similar pattern of recruitment was
obtained (Figure 3B). Together, these ChIP results show
that TBP2 is recruited to pol-II and pol-III promoters in
oocytes.
Role of TBP2 in TATA box-dependent transcription in 
oocytes
In order to further assess the role of TBP2 in oocyte tran-
scription functionally, we applied an altered binding spe-
cificity mutant reporter system [26]. In this system, three
point mutations in the carboxy terminal domain of TBP
confer the ability to bind to a mutated TATA box
(TGTAAAG) to which wild-type (wt) protein cannot bind.
We introduced these altered binding specificity (abs)
mutations in Xenopus TBP and TBP2. An EMSA was per-
formed to assess the binding specificity of wt and abs-
mutant TBP and TBP2. To this end, rabbit reticulocyte
extracts containing in vitro-translated wt and abs-mutant
versions of TBP or TBP2 were tested against regular and
mutant TATA probes from the adenovirus major late pro-
moter [20]. Like TBP, both wt and abs-mutant TBP2 pro-
teins bind to a regular TATA box, whereas only the abs-
mutant proteins bind to the altered TATA box (Figure 4A).
Next, we analyzed the behaviour of these proteins in
oocyte transcription, for which we made use of the hsp70
promoter, which is known to be active in Xenopus oocytes
and has a canonical TATA box upstream of its transcrip-
tion start site [16]. The TATA box of this promoter was
mutated to TGTA. Wild-type and the mutant promoters
were injected in the oocytes with and without mRNA
encoding TBP-abs or TBP2-abs (Figure 4B). Mutation of
the TATA box reduces transcription from this promoter,
although some transcription persists (Figure 4C). In the
presence of TBP2-abs, transcription from the TGTA pro-
moter is rescued. In contrast, wt TBP2 is unable to pro-
mote transcription from the TGTA promoter, confirming
that the rescue is specifically carried out by the exoge-
nously provided abs-mutant proteins. Interestingly, TBP-
abs, when expressed in oocytes, also rescues the transcrip-
tion to the same extent (Figure 4C) whereas the levels of
TBP2 is associated with active promoters in oocytes Figure 3
TBP2 is associated with active promoters in oocytes. (A) Chromatin immunoprecipitation (ChIP) assay on germinal 
vesical (GV)-injected promoters and endogenous 5S rRNA promoters using TBP2 and pol-II antibodies. Enrichment is the sig-
nal relative to background which in this case is the ChIP recovery from a non-promoter region (intron construct). (B) ChIP 
assay on GV-injected pol-II promoters and endogenous 5S rRNA promoter from oocytes injected with HA-TBP2 mRNA. 
Enrichment is the signal relative to background which in this case is the ChIP signal from oocytes not expressing HA-TBP2 but 
injected with the same promoter construct. Error bars in (A) and (B) represent the standard error of the mean from three 
independent experiments.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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Both TBP and TBP2 can promote transcription from TATA box containing promoters Figure 4
Both TBP and TBP2 can promote transcription from TATA box containing promoters. (A) EMSA showing the 
binding of in vitro translated wild-type and abs-mutant TBP and TBP2 to a wild-type and a mutant TATA box probe. (B) A 
scheme of the experiment shown in (C) is presented. TBP-abs or TBP2-abs mRNA was injected into stage VI oocytes. After 4 
hr oocytes were injected with either wild type or TGTA mutant hsp-70 promoter. pCMV-CAT was injected as an internal con-
trol. (C) Primer extension was performed to determine the expression from the hsp70 (hsp-70) and CMV promoter (CMV). 
Ctrl: RNA from un-injected oocytes. The bar graph shows the quantification of transcription signal from hsp-70 promoter nor-
malized with that from CMV. The error bars represent standard error of mean from three independent experiments. (D) 
Western blot analysis of TBP2-wt, TBP-abs and TBP2-abs expression in oocytes for the experiment in (C). (E) Expression 
from the ZFP36L2 promoter with regular or mutant TATA box in the presence of TBP and TBP2 abs-mutants was analyzed by 
primer extension. The bar graph shows the quantification of transcription signal from ZFP36L2 promoter normalized with that 
from CMV from two independent experiments. (F) Western blot analysis of TBP-abs and TBP2-abs expression in oocytes for 
the experiment in (E). (G) Chromatin immunoprecipitation (ChIP) assay on germinal vesical-injected promoters from oocytes 
injected with HA-TBP or HA-TBP2 mRNA. Enrichment is the signal relative to the ChIP signal from oocytes not expressing 
HA-tagged protein.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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exogenous abs proteins in both cases are comparable (Fig-
ure 4D).
We also tested the X. tropicalis ZFP36L2 promoter, which
has a canonical TATA box positioned 27 bp upstream of
the transcription start site. We generated the TGTA mutant
of this promoter and used it to test the activity of TBP and
TBP2 on this promoter. The TGTA mutation significantly
reduces transcription from this promoter (Figure 4E).
Both TBP-abs and TBP2-abs can rescue transcription, with
TBP2-abs being slightly more efficient than TBP in this
regard (Figure 4E).
Collectively, our findings show that TBP can substitute for
TBP2 if provided artificially to the oocyte core transcrip-
tion machinery. On the hsp70 and ZFP36L2 promoters,
the relative expression levels of TBP and TBP2 appear to
be a major determinant of initiation factor substitution.
To analyze the behaviour of TBP and TBP2 on promoters
lacking a TATA box, we examined the recruitment of exog-
enously provided HA-TBP and HA-TBP2 on two TATA-less
promoters (TLF, polr2h) and two TATA box-containing
promoters (hsp70, ZFP36L2). Oocytes injected with pro-
moter constructs but lacking HA-TBP/2 were used as a
negative control. Furthermore, a background control con-
struct (intron) was injected. The results substantiate the
notion that TBP, if ectopically expressed, can be recruited
to these promoters in oocytes (Figure 4G).
Loss of TBP2-promoter association during meiotic 
maturation
In addition to degrading TBP2, maturing oocytes globally
repress transcription. This prompted us to ask whether the
downregulation of TBP2 may be important for proper
shut down of transcription as oocytes mature into eggs.
This is conceivable because TBP levels are extremely rate-
limiting for transcription in egg extracts, and precocious
transcription can be induced in embryos before gene acti-
vation at the mid-blastula transition by simultaneous
inhibition of chromatin assembly with competitor DNA
and premature accumulation of TBP [15,27]. To test this
possibility, we overexpressed TBP2 in maturing oocytes.
When TBP2 is overexpressed before maturation, the levels
are also elevated after maturation (Figure 5B, bottom
panel). Therefore, stage VI oocytes were injected with two
different concentrations of TBP2 mRNA. The transcrip-
tional shut-down was investigated on two distinct pro-
moter constructs injected into oocytes either alone or in
combination with high amounts of competitor DNA (Fig-
ure 5A). The results show that repression of transcription
was established even in the presence of highly abundant
TBP2 in maturing oocytes (Figure 5B, top panel). The
overexpression of TBP2 or presence of competitor DNA,
alone or in combination, had little if any effect on the
repression of transcription.
To further examine this situation we compared the timing
of TBP2 degradation and the shutdown of transcription.
Due to the variability between individual oocytes to
undergo GVBD, batches of oocytes were synchronized
depending on the appearance of the maturation mark at
GVBD, and the promoter association of pol-II and TBP2
was determined by ChIP at GVBD and 5 hr after GVBD
(Figure 6A). The results indicate that the repression of
transcription is already established at GVBD, a point at
which TBP2 degradation has not yet initiated. These
observations (Figures 5 and 6) rule out a causative role for
TBP2 degradation in the global shutdown of transcription
during oocyte maturation, suggesting that the primary
role of TBP2 degradation is to facilitate initiation factor
switching during subsequent development. Not TBP2
degradation but rather a loss of TBP2 association with the
promoter coincides with transcriptional repression during
meiotic maturation.
Discussion
TBP2: the major TATA binding factor in oocyte 
transcription
In the present study we show that Xenopus oocytes lack
any detectable TBP, whereas TBP2 is abundant in oocytes.
In eggs and early embryos relatively low levels of TBP2 are
present. TBP starts to accumulate after meiotic maturation
and during cleavage stages of development (Figure 1A). A
similar expression profile of TBP and TBP2 has been
observed in mouse oocytes [22], which suggests a major
role for TBP2 in oocyte transcription. Indeed, TBP2 is
recruited to the transcriptionally active loops of lamp-
brush chromosomes (Figure 2). In addition, TBP2 also
appears to be a part of CBs and BSs, which are considered
to be involved in preassembly of transcription complexes
[18]. The association of TBP2 with active promoters was
further confirmed by ChIP on GV-injected promoters and
on endogenous 5S rRNA (Figure 3). Surrounding follicle
cells outnumber the oocytes; therefore it is not possible to
perform ChIP on single copy loci in oocytes. Due to this
limitation, injected promoter constructs were used to
model oocyte transcription. This system has been used
effectively to study the biochemistry of chromatin assem-
bly and transcription during oogenesis and early embryo-
genesis [28]. In order to examine the activity of TBP2 in
oocytes, we utilized an altered binding specificity (abs)
mutant reporter system [26]. It cannot be ruled out that
endogenous TBP2 behaves differently compared with its
overexpressed abs mutant. However, the involvement of
TBP2 in pol-II mediated transcription in oocytes may be
inferred from the ability of abs-TBP2 to rescue the delete-
rious effects of TGTA promoter mutations, probably due
to binding of abs-TBP2 to the TGTA sequence to which the
endogenous TBP2 cannot bind (see Figure 4). These find-
ings are congruous with the observation that only TBP2 is
present in frog and mouse oocytes with no detectable TBP,BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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Transcription repression occurs in the presence of abundant TBP2 Figure 5
Transcription repression occurs in the presence of abundant TBP2. (A) A scheme of the experiment shown in (B) is 
presented. Either 2 ng or 4 ng of TBP2 mRNA was injected into stage VI oocytes. After a delay of 12 hr oocytes were injected 
in the nucleus with 1.0 ng of hsp70 and 0.5 ng of Cyr61 promoter constructs either with or without 18 ng of competitor DNA. 
One hour after the nuclear injections oocytes were divided into two groups. One group was treated with progesterone (final 
concentration 2 μg/ml). After a further incubation of 12 hr groups of 20 healthy oocytes were collected for RNA and protein 
analysis. (B) For transcription analysis, a primer extension was performed as described in Methods. The positions of accurately 
initiated transcripts from the hsp70 (hsp-70) and Cyr61 promoter (Cyr61) are indicated. The conditions used for each lane are 
described below the gel, and at the bottom expression of TBP2 has been shown for the corresponding lane. Phospho-MAPK 
was used as a marker for maturation while TFIIF served as a loading control.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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which reinforces the notion that germ cell transcription is
different from that of somatic cells [29].
TBP2 degradation and its biological significance
We have found that during later stages of meiotic matura-
tion TBP2 protein is actively degraded (Figure 1C). This
could potentially achieve two biological goals. First, it
might be essential for proper shutdown of global tran-
scription. In early embryos, transcriptional repression can
be perturbed by premature accumulation of TBP together
with disruption of chromatin assembly [15,27]. Second,
this degradation of TBP2 in combination with the transla-
tional upregulation of TBP in embryos might be a mecha-
nism to achieve switching of TATA binding factors
between the oocyte and embryonic and/or somatic tran-
scription machineries. The results of our experiments do
not support a role for TBP2 degradation in the shutdown
of transcription as it occurs even in the presence of abun-
dant TBP2 (Figure 5), although a redundant role in tran-
scriptional repression cannot be excluded. Furthermore,
transcriptional repression is already established before
TBP2 is degraded (Figure 6). TBP2 degradation is likely to
be a mechanism that brings about the switching of TATA
binding core transcription factors, facilitating the transi-
tion from a germ cell transcription apparatus to a somatic
transcription machinery. However, this switching is not
yet complete in early embryos because of low levels of
TBP2, as discussed below.
TBP2 degradation takes place after the establishment of transcriptional shut down Figure 6
TBP2 degradation takes place after the establishment of transcriptional shut down. (A) A scheme of the experi-
ment shown in (B) is presented. Oocyte nuclei were injected with 0.6 ng of hsp70 and 0.3 ng of Cyr61 promoter constructs. 
After a delay of 12 hr oocytes were divided into two groups and one group was treated with progesterone (final concentration 
2 μg/ml). Oocytes were synchronized at germinal vesicle breakdown (GVBD). Some were processed immediately for chroma-
tin immunoprecipitation (ChIP) and immunoblotting along with control oocytes (not treated with progesterone) whereas oth-
ers were analyzed 5 hr after GVBD. (B) Recruitment of pol-II (upper graph) and TBP2 (lower graph) to hsp70 and Cyr61 
promoters in control oocytes versus oocytes at GVBD and 5 hr after GVBD was assayed by ChIP. Below the graphs expres-
sion of TBP2 has been shown corresponding to each sample. TFIIF served as a loading control.BMC Biology 2009, 7:45 http://www.biomedcentral.com/1741-7007/7/45
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The transcription machinery is highly flexible
The altered binding specificity mutant of TBP, when
expressed in the oocytes, could also promote transcription
from the hsp-70 and ZFP36L2 promoters (Figure 4). Ear-
lier observations indicated that TBP and TBP2 can replace
each other in initiating basal transcription in vitro as well
as in complexes with TFIIA/ALF and DNA [8,30,31].
Intriguingly, many promoters that exclusively require TBP
in embryos are also maternally expressed [9]. TBP protein,
however, is not present in oocytes where these maternal
transcripts were initially made, implying an initiation fac-
tor switching on these promoters between oocytes and
early embryos. Furthermore, TBP2 overexpression in TBP
knockdown embryos significantly, although not com-
pletely, rescued the phenotype of TBP ablation [8]. On a
similar note, it has been proposed that in cells hetero-
zygous for TBP (tbp +/-), elevated levels of TBP2 compen-
sate abnormally low levels of TBP at some but not all
promoters [32]. This shows that on many promoters the
two TATA binding proteins can act redundantly.
A complicating matter is that both TBP and TBP2 are
required for early development in fish and frog [5,6,8,12],
and promoters that strictly require either TBP or TBP2 in
embryos have been identified [9,10]. The molecular basis
of TBP-TBP2 selectivity remains to be elucidated. The
embryonic transcription machinery (abundant TBP, low
levels of TBP2) is not yet fully switched to the common
somatic machinery (abundant TBP, no TBP2), effectively
leaving TBP and TBP2 to compete for interactions with
embryonic activators and promoter elements. Paradoxi-
cally, despite the relatively low levels of TBP2 in embryos,
many genes depend on this factor, whereas ablation of
TBP causes relatively moderate effects on gene expression
[9]. TBP2 may be competitive in embryonic gene regula-
tion because of preferential interactions with embryonic
activators or other maternal factors that – like TBP2 – still
persist in early development; such preferential interac-
tions would be analogous to the preference of the Caudal
activator for a promoter nucleoprotein architecture with
the downstream promoter element [33]. For example,
TBP2 preferentially accommodates activation of verte-
brate-specific embryonic and ventral-specific genes [9].
During later development, core factor switching may be
completed when TBP2 levels further decline [31].
On the limited number of promoters tested in this study,
TBP and TBP2 could replace each other depending on
their relative expression levels, providing an experimental
model for initiation factor switching. Our data suggest
that the core transcription machinery is highly flexible
and that changes in relative expression levels of TATA
binding factors between oocytes and embryos can drive
core factor switching. Based on these observations we pro-
pose a model (Figure 7) according to which the core factor
switching that occurs at many maternal-embryonic pro-
moters is brought about by active degradation of TBP2
(Figures 1 and 2) followed by regulated translation of
maternal stores of TBP mRNA before the onset of embry-
onic transcription at the mid-blastula transition (MBT)
[15].
Conclusion
Our observations not only establish an important role of
TBP2 in transcription of a highly specialized cell type
which lacks any detectable TBP, but also provide evidence
that the basal transcription machinery is highly flexible
and can rapidly exchange factors depending on their
expression. This leads to initiation factor switching on a
subset of promoters that are active both in oocytes and
embryos, whereas other promoters show factor selectivity,
which accounts for their non-redundant function in early
embryos [8].
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A model of the regulation of TATA-box binding proteins  during early stages of embryogenesis Figure 7
A model of the regulation of TATA-box binding pro-
teins during early stages of embryogenesis. Oocytes 
express TBP2 which is involved in initiation of transcription. 
Upon meiotic maturation, global repression of transcription 
is established and TBP2 is actively degraded. During early 
cleavages after fertilization, maternal stores of TBP mRNA 
are translated [15] and by the mid-blastula transition (MBT) 
both TBP and residual TBP2 contribute to zygotic transcrip-
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